On August 30, 2021 I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, reported its participation in the following conferences in September (Press release, I-Mab Biopharma, AUG 30, 2021, View Source [SID1234587021]). Details of the conferences and management presentations are as follows:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies Asia Forum (Virtual)
One-on-one and small group meetings: September 9, 2021
Management participants: Dr. Jingwu Zang, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, Mr. Tianyi Zhang, Executive Director Investor Relations, Mr. Tyler Ehler, Senior Director Investor Relations and Phoebe Peng, Associate Director Investor Relations
For more information, please contact your Jefferies representative.
H. C. Wainwright 23rd Annual Global Investment Conference (Virtual)
Presentation: Monday, September 13, 2021 at 7:00 a.m. ET
Presenter: Mr. Jielun Zhu, Director and Chief Financial Officer
Webcast link: View Source The webcast will also be available under "Event Calendar" on IMAB’s IR website at View Source
One-on-one and small group meetings: September 13-15, 2021
Management participants: Dr. Jingwu Zang, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, Mr. Tianyi Zhang, Executive Director Investor Relations, Mr. Tyler Ehler, Senior Director Investor Relations and Phoebe Peng, Associate Director Investor Relations
For more information, please contact your H. C. Wainwright representative.
ICA China Biotech Corporate Access Day (Virtual)
One-on-one and small group meetings: September 23, 2021
Management participants: Dr. Jingwu Zang, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, Mr. Tianyi Zhang, Executive Director Investor Relations, Mr. Tyler Ehler, Senior Director Investor Relations and Phoebe Peng, Associate Director Investor Relations
For more information, please contact your ICA representative.
2021 Cantor Fitzgerald Global Healthcare Conference (Virtual)
Presentation: Monday, September 27, 2021 at 8:40 a.m. ET
Presenter: Mr. Jielun Zhu, Director and Chief Financial Officer
Webcast link: View Source The webcast will also be available under "Event Calendar" on IMAB’s IR website at View Source
One-on-one meetings: September 27-30, 2021
Management participants: Dr. Jingwu Zang, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, Mr. Tianyi Zhang, Executive Director Investor Relations, Mr. Tyler Ehler, Senior Director Investor Relations and Phoebe Peng, Associate Director Investor Relations
For more information, please contact your Cantor Fitzgerald representative.